论文信息 - FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer - 字舞流文

FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer

S. J. Schrieber | R. Pazdur | A. Russell | A. Al-Hakim | Todd R. Palmby | L. Amiri-Kordestani | P. Cortazar | Lijun Zhang | G. Blumenthal | R. Justice | R. Sridhara | Shenghui Tang | A. Ibrahim | N. Mehrotra | P. Song | Qi Liu | W. Weinberg | Patricia Hughes | K. Clouse | L. Ha | X. H. Chen | Qiang Xu | Jian Wang | S. Schrieber | W. D. Mcguinn | L. Skarupa | S. Miksinski | B. Chi | Reyes Candau-Chacon | Linan Ha